» Articles » PMID: 18417968

Successful Strategies for Increasing African American Participation in Cancer Genetic Studies: Hopeful Signs for Equalizing the Benefits of Genetic Medicine

Overview
Journal Community Genet
Publisher Karger
Specialty Health Services
Date 2008 Apr 18
PMID 18417968
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether prior success in recruiting African Americans to an in-house cancer genetics registry could be duplicated when recruiting to a national registry requiring a significantly increased level of commitment. Additionally, to determine which recruitment sources and practices yielded the highest number of African American participants.

Methods: A retrospective analysis of recruitment sources, practices, and results for recruitment to the Cancer Genetics Network (CGN; a national research registry), from 2000 to 2005 was conducted. These results were compared to previous experience in recruiting African Americans to the Family Cancer Registry (FCR; an in-house registry) during the period 1992-2005.

Results: In the 1st year of recruitment to the CGN, African Americans accounted for 24% of those consenting to participate in the CGN registry from our center. This compares to an average annual rate of 27% for the FCR during the years 1998-2005, and a rate of less than 1% from 1992 to 1998. By 2005, African Americans accounted for 27% of CGN participants recruited through the University of Texas Southwestern Medical Center, one of eighteen participating institutions in the CGN. Hospital-based resources such as cancer treatment clinics and tumor registries yielded the highest percentage of African American participants (66.5%), and self-referral yielded the lowest (0%). Seventy-seven percent of African Americans were actively sought out and recruited from treatment clinics, whereas the vast majority of Caucasian participants were recruited passively during the course of genetic counseling sessions that were scheduled for reasons unrelated to participation in cancer research. There were no known instances of African Americans contacting CGN staff after reading printed recruitment materials or internet advertisements.

Conclusions: The increased level of commitment required of CGN participants did not deter African Americans from participating in cancer genetics research. Recruitment strategies responsible for dramatically increasing recruitment rates to the FCR from 1998 to 2000 were equally effective when used for recruitment to the CGN. The most effective recruitment sources were high-yield venues such as cancer treatment clinics and tumor registries, and active recruitment methods yielded the highest number of African American participants. Advertising through internet announcements and printed recruitment materials did not appear to be effective.

Citing Articles

Recruitment strategies and lessons learned from a large genetic study of African Americans.

Salowe R, Lee R, Zenebe-Gete S, Vaughn M, Gudiseva H, Pistilli M PLOS Glob Public Health. 2023; 2(8).

PMID: 36743904 PMC: 9897316. DOI: 10.1371/journal.pgph.0000416.


Why African Americans say "No": A Study of Pharmacogenomic Research Participation.

Nooruddin M, Scherr C, Friedman P, Subrahmanyam R, Banagan J, Moreno D Ethn Dis. 2020; 30(Suppl 1):159-166.

PMID: 32269457 PMC: 7138442. DOI: 10.18865/ed.30.S1.159.


Cost and yield considerations when expanding recruitment for genetic studies: the primary open-angle African American glaucoma genetics study.

Salowe R, OKeefe L, Merriam S, Lee R, Khachatryan N, Sankar P BMC Med Res Methodol. 2017; 17(1):101.

PMID: 28705151 PMC: 5512952. DOI: 10.1186/s12874-017-0374-9.


Sociocultural variation in attitudes toward use of genetic information and participation in genetic research by race in the United States: implications for precision medicine.

Dye T, Li D, Demment M, Groth S, Fernandez D, Dozier A J Am Med Inform Assoc. 2016; 23(4):782-6.

PMID: 26984047 PMC: 4926739. DOI: 10.1093/jamia/ocv214.


What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.

Adams I, Christopher J, Williams K, Sheppard V J Cancer Educ. 2014; 30(2):344-52.

PMID: 25301325 PMC: 4393763. DOI: 10.1007/s13187-014-0740-9.